Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Herzig

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Cancer Treatment Reports|May 1, 1985
Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantationH M Lazarus, R H Herzig, S N Wolff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Endogenous CD8+ T cell expansion during regression of monoclonal EBV-associated posttransplant lymphoproliferative disorderV P Khatri, R A Baiocchi, R Peng, et al.
Progress in Clinical and Biological Research|January 1, 1992
Bone marrow purging in patients with refractory cancerR C Meagher, D A Stevens, G P Herzig, et al.
Blood|November 11, 1975
Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentratesR H Herzig, G P Herzig, M I Bull, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation GroupS N Wolff, R H Herzig, J W Fay, et al.
Seminars in Oncology|June 1, 1987
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an updateS N Wolff, R H Herzig, G L Phillips, et al.
Medical and Pediatric Oncology|January 1, 1982
Bone marrow transplantation with high-dose cytosine arabinosideR H Herzig, H M Lazarus, J Graham-Pole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapyM Wetzler, M R Baer, S H Bernstein, et al.
Leukemia & Lymphoma|August 26, 1998
Expression and function of the megakaryocyte growth and development factor receptor in acute myeloid leukemia blastsM Wetzler, S H Bernstein, H Baumann, et al.
Annals of Internal Medicine|June 15, 1993
High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant GroupS N Wolff, J W Fay, R H Herzig, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Cancer Treatment Reports|May 1, 1985
Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantationH M Lazarus, R H Herzig, S N Wolff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Endogenous CD8+ T cell expansion during regression of monoclonal EBV-associated posttransplant lymphoproliferative disorderV P Khatri, R A Baiocchi, R Peng, et al.
Progress in Clinical and Biological Research|January 1, 1992
Bone marrow purging in patients with refractory cancerR C Meagher, D A Stevens, G P Herzig, et al.
Blood|November 11, 1975
Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentratesR H Herzig, G P Herzig, M I Bull, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation GroupS N Wolff, R H Herzig, J W Fay, et al.
Seminars in Oncology|June 1, 1987
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an updateS N Wolff, R H Herzig, G L Phillips, et al.
Medical and Pediatric Oncology|January 1, 1982
Bone marrow transplantation with high-dose cytosine arabinosideR H Herzig, H M Lazarus, J Graham-Pole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapyM Wetzler, M R Baer, S H Bernstein, et al.
Leukemia & Lymphoma|August 26, 1998
Expression and function of the megakaryocyte growth and development factor receptor in acute myeloid leukemia blastsM Wetzler, S H Bernstein, H Baumann, et al.
Annals of Internal Medicine|June 15, 1993
High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant GroupS N Wolff, J W Fay, R H Herzig, et al.
Pageof 9